Home
  >  
Section 47
  >  
Chapter 46,963

Ph+ acute myelogenous leukemia with t (7;11) (p15;p15) and clonal evolution in relapse after bone marrow transplantation

Miura, I.; Nishinari, T.; Hashimoto, K.; Nimura, T.; Takatsu, H.; Niitsu, H.; Hirokawa, M.; Kuwayama, A.; Nishimura, S.; Miura, A.B.

Acta Haematologica 90(3): 148-150

1993

ISSN/ISBN: 0001-5792
PMID: 8291375
DOI: 10.1159/000204397
Accession: 046962962
Download citation:  
Text
  |  
BibTeX
  |  
RIS
A 20-year-old female with Ph+ acute myelogenous leukemia (M2) associated with t(7;11)(p15;p15) is reported. Bone marrow aspirates were hypercellular with leukemic cells including Auer rods. Chromosome analysis showed t(7;11) and the Ph chromosome. After complete remission, normal karyotype was restored. Normal male karyotypic cells replaced the bone marrow following allogeneic bone marrow transplantation from her brother. On day 358, cytogenetic study at relapse revealed 14q+ as an additional change and clearly showed that the abnormal clone was derived from the patient, because metaphases with XX were all of abnormal karyotype and those with XY were normal.

Full Text Article emailed within 0-6 h: $19.90




Related References

Michel, G.; Boulad, F.; Small, T.N.; Black, P.; Heller, G.; Castro-Malaspina, H.; Childs, B.H.; Gillio, A.P.; Papadopoulos, E.B.; Young, J.W.; Kernan, N.A.; O'Reilly, R.J. 1997: Risk of extramedullary relapse following allogeneic bone marrow transplantation for acute myelogenous leukemia with leukemia cutis Bone Marrow Transplantation 20(2): 107-112
Einsele, H.; Ehninger, G.; Vallbracht, A.; Kömpf, J.; Schmidt, H.; Kandolf, R.; Jahn, G.; Müller, C. 1989: Isolated pericardial relapse following allogeneic bone marrow transplantation for acute myelogenous leukemia Bone Marrow Transplantation 4(3): 323-325
Creutzig, U.; Ritter, J.; Zimmermann, M.; Schellong, G. 1993: Does cranial irradiation reduce the risk for bone marrow relapse in acute myelogenous leukemia? Unexpected results of the Childhood Acute Myelogenous Leukemia Study BFM-87 Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 11(2): 279-286
Lehmann, L.E.; Guinan, E.C.; Halpern, S.L.; Donovan, M.J.; Bierer, B.E.; Parsons, S.K. 1997: Isolated testicular relapse in an adolescent 5 years following allogeneic bone marrow transplantation for acute myelogenous leukemia Bone Marrow Transplantation 19(8): 849-851
Simpson, D.R.; Vickars, L.M.; Fung, H.C.; Naiman, S.C.; Horsman, D.E.; Shepherd, J.D.; Nantel, S.H.; Sutherland, H.J.; Klingemann, H.G.; Toze, C.L.; Barnett, M.J. 1995: Relapse of acute myelogenous leukemia at extramedullary sites after allogeneic bone marrow transplantation with busulfan and cyclophosphamide conditioning Blood 86(10 Suppl 1): 966A
Dann, E.J.; Gillis, S.; Rowe, J.M. 1995: Late relapse following autologous bone marrow transplantation for acute myelogenous leukemia: case report and review of the literature Leukemia 9(6): 1072-1074
Michel, G.; Boulad, F.; Small, T.; Black, P.; Heller, G.; Childs, B.; Castro Malaspina, H.; Gillio, A.; Mackinnon, S.; Papadopoulos, E.; Young, J.; Kernan, N.A.; O'reilly, R.J. 1994: Risk of relapse after allogeneic bone marrow transplantation for the treatment of acute myelogenous leukemia with prior skin involvement Blood 84(10 Suppl 1): 207A
Venkateswaran, L.; Duerst, R.; Haut, P.; Kletzel, M.; Chou, P. 2002: Bone marrow necrosis associated with relapse of acute myelogenous leukemia following unrelated hematopoeitic stem cell transplantation using an immunoablative regimen Medical and Pediatric Oncology 38(2): 148-149
Mittermueller, J.; Kolb, H.J.; Wilmanns, W. 1984: Evidence of chimerism by means of phosphoglucomutase 1 isoenzyme typing prior to and during relapse of acute myelogenous leukemia after bone marrow transplantation Blut 49(3): 293
Kikushige, Y.; Takase, K.; Miyamoto, T.; Numata, A.; Kamesaki, K.; Fukuda, T.; Nagafuji, K.; Gondo, H.; Harada, M. 2006: Late relapse of acute myelogenous leukemia followed by epstein-barr virus-associated lymphoproliferative disease 11 years after allogeneic bone marrow transplantation International Journal of Hematology 84(5): 441-444
Holland, H.K.; Bray, R.A.; O'toole, K.; Holden, J.T.; Connaghan, D.G.; Heffner, L.T.; Waller, E.K.; Winton, E.F.; Yeager, A.M. 1997: Presence of minimal residual disease in acute myelogenous leukemia patients preallogenic bone marrow transplantation is associated with a lower relapse-free survival Experimental Hematology 25(8): 905
Kalhs, P.; Schwarzinger, I.; Mori, M.; Storb, R.; Clift, R.; Buckner, C.D.; Thomas, E.D.; Sullivan, K.M. 1991: Splenectomy prior to allogeneic bone marrow transplantation bmt for chronic myelogenous leukemia cml analysis of posttransplant infection acute gvhd relapse and survival Onkologie 14(Suppl 2): 78
Sao, H.; Kato, C.; Kitaori, K.; Adachi, T.; Yano, K.; Kobayashi, M.; Kojima, H.; Tanimoto, M.; Hirabayashi, N.; Minami, S.; Yamada, H.; Morishita, G.Y.; Morishima, Y.; Kodera, Y. 2000: Effective and safe interferon treatment for Japanese patients with chronic myelogenous leukemia relapse after bone marrow transplantation. the Nagoya Blood and Marrow Transplantation Group International Journal of Hematology 72(2): 237-242
Papadopoulos, E.B.; Carabasi, M.H.; Castro-Malaspina, H.; Childs, B.H.; Mackinnon, S.; Boulad, F.; Gillio, A.P.; Kernan, N.A.; Small, T.N.; Szabolcs, P.; Taylor, J.; Yahalom, J.; Collins, N.H.; Bleau, S.A.; Black, P.M.; Heller, G.; O'Reilly, R.J.; Young, J.W. 1998: T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host disease Blood 91(3): 1083-1090
Ikeuchi, K.; Doki, N.; Takao, A.; Hishima, T.; Yamada, Y.; Konishi, T.; Nagata, A.; Takezaki, T.; Kaito, S.; Kurosawa, S.; Sakaguchi, M.; Harada, K.; Yasuda, S.; Yoshioka, K.; Watakabe-Inamoto, K.; Igarashi, A.; Najima, Y.; Muto, H.; Kobayashi, T.; Kakihana, K.; Sakamaki, H.; Ohashi, K. 2017: Extramedullary Gastric Relapse at the time of Bone Marrow Relapse of Acute Lymphoblastic Leukemia after Allogeneic Bone Marrow Transplantation Internal Medicine 56(23): 3215-3217
Heinze, B.; Arnold, R.; Kratt, E.; Bunjes, D.; Reess, K.; Plecity, P.; Heimpel, H.; Fliedner, T.M. 1991: Kinetics of relapse of leukemia after bone marrow transplantation: cytogenetic follow up of patients with chronic myelogenous leukemia Bone Marrow Transplantation 7(Suppl 2): 16
Bordigoni, P.; Cavazzana Calvo, M.; Michel, G.; Gluckman, E.; Baruchel, A.; Reiffers, J.; Souillet, G.; Milpied, N.; Pico, J.L.; Bernaudin, F.; Cornu, G.; Leverger, G.; Plouvier, E.; Lacour, B.; Fischer, A. 1995: Allogenic bone marrow transplantation versus autologous bone marrow transplantation for the treatment of childhood acute lymphoblastic leukemia in second remission after early marrow relapse Blood 86(10 Suppl 1): 939A
Offit, K.; Burns, J.P.; Cunningham, I.; Jhanwar, S.C.; Black, P.; Kernan, N.A.; O'Reilly, R.J.; Chaganti, R.S. 1990: Cytogenetic analysis of chimerism and leukemia relapse in chronic myelogenous leukemia patients after T cell-depleted bone marrow transplantation Blood 75(6): 1346-1355
Frassoni, F.; Labopin, M.; Palut Mzali, P.; Buchner, T.; Burnett, A.; Clink, H.M.; Gluckman, E.; Goldstone, A.; Gratwohl, A. 1993: Evolution of allogeneic bone marrow transplantation in Europe Improved results for patients with acute leukemia in first remission For the Acute Leukemia Working Party of the European Group for Bone Marrow Transplantation Blood 82(10 Suppl 1): 291A
Shah, N.K.; Wagner, J.; Santos, G.; Griffin, C.A. 1992: Karyotype at relapse following allogeneic bone marrow transplantation for chronic myelogenous leukemia Cancer Genetics and Cytogenetics 61(2): 183-192